WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq:NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced the launch of www.DPNCheck.com. The website is an important online resource that will help support the growing domestic and international DPNCheck® business. DPNCheck is a fast, accurate and quantitative point-of-care test for diabetic peripheral neuropathy, or DPN. The DPNCheck test addresses an unmet medical need for better and more cost-effective screening, diagnosing and monitoring of DPN. This complication affects over 50% of people with diabetes and leads to foot ulcers and limb amputation, as well as severe pain and an overall reduction in patient quality of life.
Help employers find you! Check out all the jobs and post your resume.
